Close Menu

gene expression

Under terms of the deal, Novartis will give Epistem a $4 million upfront payment and provide funding to study the stem cell shop's drug targets. Epistem could also get up to $45 million in milestone payments for each product developed from targets licensed under the agreement.

HHMI and University of Washington researcher Evan Eichler led a team of researchers who found evidence suggesting a gene called IRGM became a pseudogene in the ancestor of monkeys and apes before being resurrected in the human-great ape lineage.

Papers of Note for Feb 2009

Premium

RNAi-Related Papers Published Feb. 2009

IP Update: Mar 5, 2009

Premium

USPTO Publishes One Patent, Eight Patent Applications Related to RNAi

Patent Reform Act reintroduced; FDA clears UF-developed wound care tech; GSK inks ophthalmology research pact with University College London, and more ...

Qiagen said that PreAnalytix's PAXgene system is now the only collection, stabilization, and purification method — either automated or manual — available in the US for IVD use.

Using gene expression and copy number analyses of dozens of endometrial cancers, an international research team has turned up characteristic expression profiles and gene amplifications linked to poor outcomes.

For Agilent, the debut of SurePrint G3 caps a year of upgrading its microarray platform. The density upgrade also comes at a time when all other major array companies have made similar improvements with their platforms.

In Print: Mar 3, 2009

Premium

Microarray-Related Papers of Note, February 2009

BioArray Briefs: 2009.03.03

Premium

Febit, READNA Consortium, US Department of Agriculture, Autogenomics, Oxford Gene Technology, Optra, Gene Logic, Genstruct, Global Biomarker Conference

Pages

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.